• Home
  • Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.

Author List
Harding JJ, Do RK, Yaqubie A, Cleverly A, Zhao Y, Gueorguieva I, Lahn M, Benhadji KA, Kelley RK, Abou-Alfa GK
Publication
Cancer medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/186877673
Publication Year
2021
PubMed ID
33811482
Publication Title
Harding JJ, Do RK, Yaqubie A, Cleverly A, Zhao Y, Gueorguieva I, Lahn M, Benhadji KA, Kelley RK, Abou-Alfa GK. Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma. Cancer Med. 2021 05; 10(9):3059-3067.